A Newspaper for the health conscious


Pinorc Life Science

Jain favours 100% autonomy for Delhi Govt. hospitals

1 1 1 1 1 1 1 1 1 1 Rating 4.75 (2 Votes)

 Rohit Shishodia
Delhi’s health minister Satyendra Jain has batted for full autonomy for all Delhi government run hospitals as this would reduce the administrative hurdles such as clearing of hospital related files by officials.

“I am of the view that there should be hundred per cent autonomy for hospitals. Giving autonomy to hospitals will bring efficiency in provision of health services. Come to us only for money once in a year. Our work is just to support hospitals,” said Jain while speaking at an event in Guru Teg Bahadur Hospital.

“But here is the problem that no official wants to lose his or her power. Everybody wants to show his power. I do not know why the officials do not clear files. You can’t keep files for two hours or a day, if you are to make medicines available to patients, then you have to do it. There should be not even five minute delay in provision of healthcare services. I agree that there should be autonomy for hospitals,” added Jain.

The health minister informed that the Delhi government is outsourcing manpower for pharmacies in hospitals that is expected to reduce the waiting time of patients who keep standing for hours to get medicines. It will take three months to implement this.

The health minister said that small hospitals which have 200 beds will be converted to 400 bedded hospitals in future. The minister expressed unhappiness over the lack of knowledge among doctors who are referring patients to bigger hospitals for just tests that have been made free in private hospitals.

“The doctors from small hospitals refer patients to GTBH for just getting the test done. You can send the patient to the private centre for the test as government will pay for it. People gradually know the welfare schemes brought by the Delhi government. Around fifty thousand patients have availed the free scheme so far,” said the health minister.

Leave your comments



  • No comments found


  • No comments found
GLS Pharma

Cubit Pharma